Henry Smith – 2016 Parliamentary Question to the Department of Health
The below Parliamentary question was asked by Henry Smith on 2016-06-27.
To ask the Secretary of State for Health, what assessment he has made of the implications for his policies of the findings of the National Cancer Patient Experience Survey 2015 on the proportion of blood cancer patients that understood the explanation given to them at diagnosis; and if he will take steps to increase support for such patients at the point of diagnosis.
Jane Ellison
It is important that people with cancer have the best possible experience throughout their cancer pathway and are treated with dignity and respect.
The independent Cancer Taskforce published its report Achieving World-Class Cancer Outcomes – A Strategy for England 2015-2020 in July 2015, and identified a key priority of establishing patient experience as being on a par with clinical effectiveness and safety. In May 2016 the National Cancer Transformation Board published Achieving World-Class Cancer Outcomes: Taking the Strategy Forward outlining the detailed steps being taken to make this a reality.
In September 2015, the Government announced that by 2020, the 280,000 people diagnosed with cancer every year will benefit from a tailored recovery package. The packages will be individually designed to help each person, including those with blood cancer, live well beyond cancer. In April 2016 NHS England published guidance for commissioners on commissioning and implementing the recovery package effectively.
In order to continue to support general practitioners (GPs) to identify patients whose symptoms may indicate cancer and urgently refer them as appropriate, the National Institute for Health and Care Excellence (NICE) published an updated suspected cancer referral guideline in June 2015. The guideline includes new recommendations for haematological cancers. NICE noted that more lives could be saved each year in England if GPs followed the new guideline, which encourages GPs to think of cancer sooner and lower the referral threshold. Following publication of the updated guideline, the Royal College of GPs (RCGP) has worked in collaboration with Cancer Research UK (CRUK) on a programme of regional update events for GPs to promote the new guideline. RCGP and CRUK have also worked to develop three summary referral guidelines for GPs to enable them to adopt the guideline. These are available at:
“
